The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of TILs indices generated by visual review and digital computational algorithm with outcomes from preoperative chemotherapy for TNBC in TBCRC 030.
 
Guilherme Nader Marta
Travel, Accommodations, Expenses - AstraZeneca
 
Xiangying Chu
No Relationships to Disclose
 
Satabhisa Mukhopadhyay
Employment - 4D Path
Leadership - 4D Path
Stock and Other Ownership Interests - 4D Path
 
Vandana G Abramson
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Guardant Health
Research Funding - Bayer; Guardant Health
 
Adam Brufsky
Consulting or Advisory Role - Agendia; Daiichi Sankyo/Lilly; Eisai; Genentech/Roche; General Electric; Gilead Sciences; Lilly; Merck; Michael J. Hennessy Associates; Myriad Pharmaceuticals; Novartis; Onc Live; Pfizer; Puma Biotechnology; Seagen
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst)
Expert Testimony - Pfizer
 
Erica Michelle Stringer-Reasor
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Lilly; Merck; Merck; Novartis; Pumas-AI; Pumas-AI; Seagen
Research Funding - Susan G. Komen for the Cure; V Foundation
 
Susan Faye Dent
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; BMS US; Gilead Sciences; Myocardial Solutions; Novartis; Pfizer
Research Funding - Novartis (Inst)
 
Tiffany A. Traina
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Exact Sciences; G1 Therapeutics; Genentech/Roche; Gilead Sciences; GlaxoSmithKline; Hengrui Pharmaceutical; Merck; Pfizer; Stemline Therapeutics; Tersera
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Pfizer (Inst)
 
Lisa A. Carey
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Lilly (Inst); NanoString Technologies (Inst); Novartis (Inst); Seagen (Inst); Veracyte (Inst)
(OPTIONAL) Uncompensated Relationships - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly; Novartis (Inst); SeaGen
 
Mothaffar F. Rimawi
Consulting or Advisory Role - AstraZeneca; Macrogenics; Novartis; Pfizer; Sermonix Pharmaceuticals
 
Jennifer M. Specht
Honoraria - Daiichi Sankyo; GE Healthcare; GlaxoSmithKline; Sensei Biotherapeutics
Consulting or Advisory Role - Daiichi Sankyo; GE Healthcare; GlaxoSmithKline; Lyell Immunopharma Inc; Sensei Biotherapeutics; Volastra Therapeutics
Research Funding - Abbvie (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Carisma Therapeutics (Inst); Cascadian Therapeutics (Inst); Celcuity (Inst); Genentech (Inst); Lyell Immunopharma (Inst); Merck (Inst); Myriad Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - UW CoMotion - Patent Royalty for ROR1 CAR (Inst)
Travel, Accommodations, Expenses - A2 Biotherapeutics; GE Healthcare; GlaxoSmithKline; Nektar
 
Kathy Miller
Consulting or Advisory Role - AstraZeneca; Celcuity; Genentech/Roche; Merck
Research Funding - Astex Pharmaceuticals (Inst); CytomX Therapeutics (Inst); Pfizer (Inst)
 
Cesar Augusto Santa-Maria
Consulting or Advisory Role - Abbvie; Athenex; Bristol-Myers Squibb; Calibr; Genomic Health; Halozyme; Merck; Pfizer; Pfizer; Polyphor; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Genentech (Inst); Medimmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Tesaro (Inst)
 
Tathagata Dasgupta
Employment - 4D Path
Leadership - 4D Path
Stock and Other Ownership Interests - 4D Path
 
Busem Binboğa Kurt
No Relationships to Disclose
 
Nabihah Tayob
No Relationships to Disclose
 
Ian E. Krop
Employment - PureTech (I)
Leadership - PureTech (I)
Stock and Other Ownership Interests - PureTech (I)
Honoraria - AstraZeneca; Daiichi Sankyo
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Genentech/Roche; Merck; Novartis; Seagen
Research Funding - Genentech (Inst); Macrogenics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - anti-murine CD19 monoclonal antibody licensed to PharMingen
 
Nadine M. Tung
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
Research Funding - AstraZeneca (Inst)
 
Stuart J. Schnitt
Consulting or Advisory Role - IBEX Medical Analytics; PathAI
 
Erica L. Mayer
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis